EP
BNTC icon

Essential Partners’s Benitec Biopharma BNTC Stock Holding History

Essential Partners’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$160 Buy
+16
New +$196 ﹤0.01% 2635

Other funds holding BNTC

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners's BNTC Position: Q3 2026 in Review

Essential Partners opened a new position in Benitec Biopharma (BNTC) in Q3 2026: 16 shares worth $160. The stake represents ﹤0.01% of the portfolio and ranks #2635 among its holdings.

4 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • Essential Partners held 16 shares of Benitec Biopharma worth $160 as of Q3 2026.
  • Benitec Biopharma was a new Essential Partners position in Q3 2026.
  • Benitec Biopharma made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2635 holding.
  • 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.